BT-InnoVaChem is an innovative and emerging science-based university spin-off, in the field of antimicrobial chemicals. The ever-increasing bacterial and fungal resistance to common antimicrobial agents is highlighting the urgent need to develop new active ingredients to treat infections caused by resistant pathogens. To this purpose, BT-InnoVaChem offers a novel and green technology for the produ
ction at industrial level of a new and efficient antimicrobial agent called bromothymol (BT), that is still unused. The key success factors for the introduction of this innovation are:
higher BT antimicrobial efficacy (up to 15 times) and lower toxicity than other active ingredients;
efficency of the production process;
low environmental impact
the know-how and patent. Despite its promising features, BT is still not used in industries because of its high price and not-acceptable purity, that make it unsuitable in biomedical applications. However, BT-InnoVaChem business idea deals with production and marketing of bromothymol, obtained through its innovative, highly efficient and low-cost process. Our idea is to sell BT to industries working in the formulation of personal-care and surface disinfection products through a B2B model, because BT may efficiently replace other commonly used active ingredients. The scope is very broad and it can cover almost the totality of the biocide market, which worths more than 10 billion $ worldwide each year. The team is composed by young researchers and professors in Chemical Sciences, Managment and Industrial Engineering from University of Rome "Tor Vergata", covering all the necessary skills.
